Andreas Hohlbaum,Hendrik Gille,Stefan Trentmann,Laurent Audoly,Andrea Allersdorfer
申请号：
US15938117
公开号：
US20180311311A1
申请日:
2018.03.28
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure relates to methods of treating, ameliorating or preventing a disorder comprising administering a therapeutically effective amount of a composition to a subject in need thereof, which composition contains a lipocalin mutein or a fragment or a variant thereof capable of increasing the bioavailability of iron in the subject.
